Antimetastatic Activity of Combined Topotecan and Tyrosyl-DNA Phosphodiesterase-1 Inhibitor on Modeled Lewis Lung Carcinoma

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	661-666
Number of pages	6
Journal	Bulletin of Experimental Biology and Medicine
Volume	166
Issue number	5
DOIs	https://doi.org/10.1007/s10517-019-04413-3
Publication status	Published - 15 Mar 2019

Lewis lung carcinoma, metastases, morphometry, topotecan, tyrosyl-DNA phosphodiesterase-1 inhibitor

ID: 19038248